ICICI Prudential Life Insurance Company Limited has announced scheduled investor meetings for February 3-4, 2026, at the ICICI Securities Annual Investor Conference in Singapore. The company filed the regulatory disclosure on January 16, 2026, under Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.

Meeting Schedule and Details

The insurance company has organized two group meetings with investors and analysts during the conference. Both sessions will be conducted in-person in Singapore as part of the ICICI Securities Annual Investor Conference.

Regulatory Compliance

The disclosure was made in accordance with Regulation 30 read with para A of part A of Schedule III and Regulation 46(2) of Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015. Company Secretary Priya Nair signed the regulatory filing, emphasizing the company's commitment to transparency and compliance.

Key Highlights

The company has outlined several important aspects of these investor meetings:

• The meeting schedule remains subject to change due to exigencies on the part of investors or the company
• No unpublished price sensitive information will be shared during the meetings
• Both sessions are structured as group meetings rather than one-on-one interactions
• The meetings form part of ICICI Securities' broader annual investor conference in Singapore

These investor meetings represent ICICI Prudential Life Insurance's ongoing efforts to maintain regular communication with the investment community and provide updates on business developments within regulatory frameworks.

ICICI Prudential Life Insurance has received a revised research rating from Goldman Sachs, with the global investment bank maintaining its neutral stance while adjusting the target price downward.

Goldman Sachs Rating Update

The investment bank has retained its neutral rating on ICICI Prudential Life Insurance while cutting the target price to ₹690.00 per share. This revision represents Goldman Sachs' updated assessment of the life insurance company's stock valuation.

Market Implications

The neutral rating suggests that Goldman Sachs analysts view the stock as fairly valued at current levels, neither recommending it as a strong buy nor advising investors to sell. The target price reduction to ₹690.00 indicates a more conservative valuation approach by the brokerage firm.

This research update comes as part of Goldman Sachs' ongoing coverage of the Indian life insurance sector, where ICICI Prudential Life Insurance operates as one of the leading private sector players. The revised target price provides investors with Goldman Sachs' updated fair value assessment for the company's shares.